ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Welcome to the ACR/ARP Abstracts Website

There are several ways to explore this site:

  1. Browse 2020 abstracts in numerical order.
  2. Browse 2020 abstracts by viewing the list of session titles.
  3. View abstracts about a certain topic by visiting the keyword index.
  4. Search this site for a specific abstract.
  5. Access the meetings archive to view abstracts from previous meetings.
  6. Register or log in to save favorites.

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

Archives

Archives

View available meetings

Search

Search

Search abstracts in detail

Download

Download

Abstracts PDFs

Recent Meetings

ACR Convergence 2020
November 5-9, 2020
All Virtual
2020 Pediatric Rheumatology Symposium
April 29-May 2, 2020

2020 Late-Breaking Abstracts

  • Abstract Number: L01
    Outcomes of COVID-19 Infection in Patients with Rheumatic Diseases in a Multicenter Healthcare System: A Comparative Cohort Study
  • Abstract Number: L02
    Risk Mitigating Behavior in People with Rheumatic Diseases or Psoriasis During the COVID-19 Pandemic Differ by Immunosuppressant Treatment Type: A Patient survey Study
  • Abstract Number: L03
    Efficacy and Safety of Deucravacitinib (BMS-986165), an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Active Psoriatic Arthritis: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
  • Abstract Number: L04
    Influenza Adverse Events in Patients with Rheumatoid Arthritis in the Tofacitinib Clinical Program
  • Abstract Number: L05
    DMARD Changes for Patients with Rheumatoid Arthritis in the US During the First Three Months of the COVID-19 Pandemic
  • Abstract Number: L06
    Mavrilimumab (anti GM-CSF Receptor α Monoclonal Antibody) Reduces Time to Flare and Increases Sustained Remission in a Phase 2 Trial of Patients with Giant Cell Arteritis
  • Abstract Number: L07
    Tocilizumab for COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial
  • Abstract Number: L08
    Long Term Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Chronic Gout: The Febuxostat versus Allopurinol Streamlined Trial (on Behalf of the FAST Investigators)
  • Abstract Number: L09
    A Phase 2a Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA)
  • Abstract Number: L10
    Targeting Plasmacytoid Dendritic Cells Improves Cutaneous Lupus Erythematosus Skin Lesions and Reduces Type I Interferon Levels: Results of a Phase 1 Study of VIB7734
  • Abstract Number: L11
    Tofacitinib for the Treatment of Adult Patients with Ankylosing Spondylitis: Primary Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.